Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial., Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2019.37.15_suppl.5500.
You can read the full text:
Contributors
The following have contributed to this page
